Dyne Therapeutics, Inc. DYN Increase (Decrease) in Accounts Payable and Other Operating Liabilities
Increase (Decrease) in Accounts Payable and Other Operating Liabilities at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s increase (decrease) in accounts payable and other operating liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s increase (decrease) in accounts payable and other operating liabilities?
- Dyne Therapeutics, Inc. (DYN) reported increase (decrease) in accounts payable and other operating liabilities of -$4.8M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s increase (decrease) in accounts payable and other operating liabilities changed year-over-year?
- Dyne Therapeutics, Inc.'s increase (decrease) in accounts payable and other operating liabilities increased by 44.1% year-over-year, from -$8.6M to -$4.8M.